Lupin recalls over 51,000 bottles of antibiotic in the US
Megha Jain
Content Head
Image Credit: newsbyte
Lupin, an Indian multinational pharmaceutical giant, is recalling 51,006 bottles of Cefdinir for Oral Suspension (250mg/5mL) from the US market. This is due to a "defective container: lack of seal integrity," as stated by the US Food and Drug Administration (USFDA). This medication, used for treating various bacterial infections, was manufactured at Lupin's Mandideep-based plant and distributed in the US, by Baltimore-based Lupin Pharmaceuticals, Inc. The USFDA classifies this as a Class II recall.
